Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec(®), Gleevec™)

Treatment options for chronic myeloid leukemia (CML) have changed dramatically during the last decades. Interferon-α treatment and stem cell transplantation (SCT) clearly improved survival over conventional chemotherapy and offered the possibility of complete and durable responses. With the advent o...

Descripción completa

Detalles Bibliográficos
Autores principales: Henkes, Martin, van der Kuip, Heiko, Aulitzky, Walter E
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2503652/
https://www.ncbi.nlm.nih.gov/pubmed/18728706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2503652/
https://www.ncbi.nlm.nih.gov/pubmed/18728706

Ejemplares similares